March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Clinical utility of Ophthalmic Antimicrobial Susceptibility Measurement Plate
Author Affiliations & Notes
  • Norihiko Tou
    Ophthalmology, Univ of Occup & Environ Health, Kitakyushu-shi, Japan
  • Ryohei Nejima
    Miyata Eye Hospital, Miyazaki, Japan
  • Yoshifumi Ikeda
    Department of Ophthalmology, Tottori Univ Faculty of Medicine, Yonago, Japan
  • Yuichi Hori
    Ophthalmology, Toho University Sakura Medical Center, Sakura, Japan
  • Kaoru Sasaki
    Ideta Eye Hospital, Kumamoto, Japan
  • Masako Sakamoto
    Ophthalmology, The Research Foundation for Microbial Diseases of Osaka University, Osaka, Japan
  • Kazunori Miyata
    Miyata Eye Hospital, Miyazaki, Japan
  • Yoshitsugu Inoue
    Department of Ophthalmology, Tottori Univ Faculty of Medicine, Yonago, Japan
  • Akihiko Tawara
    Ophthalmology, Univ of Occup & Environ Health, Kitakyushu-shi, Japan
  • Hiromitsu Fujiwara
    Department of Clinical Laboratory, Tottori University Hospital, Yonago, Japan
  • Footnotes
    Commercial Relationships  Norihiko Tou, None; Ryohei Nejima, None; Yoshifumi Ikeda, None; Yuichi Hori, None; Kaoru Sasaki, None; Masako Sakamoto, None; Kazunori Miyata, None; Yoshitsugu Inoue, None; Akihiko Tawara, None; Hiromitsu Fujiwara, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 6261. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Norihiko Tou, Ryohei Nejima, Yoshifumi Ikeda, Yuichi Hori, Kaoru Sasaki, Masako Sakamoto, Kazunori Miyata, Yoshitsugu Inoue, Akihiko Tawara, Hiromitsu Fujiwara; Clinical utility of Ophthalmic Antimicrobial Susceptibility Measurement Plate. Invest. Ophthalmol. Vis. Sci. 2012;53(14):6261.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose:
 

To evaluate the clinical utility of SG17 (Ophthalmic Antimicrobial Susceptibility Measurement Plate:Fig1), newly developed plate to measure the minimum inhibitory concentration (MIC) for bacterial isolates of ocular infection.

 
Methods:
 

Antimicrobial susceptibility was measured using 96 strains detected from 78 patients diagnosed as ocular infection in five institutes. The clinical utility of SG17 was evaluated to compare MIC measured by SG17 to susceptibility measured by routine method at each institute.

 
Results:
 

Of the 96 strains, 85(88.5%) were gram positive strains, those of 34(35.4%) were coagulase-negative Staphylococci, 22(22.9%) were Corynebacterium spp. and 15(15.6%) were Staphylococcus aureus. SG17 measured MIC up to higher concentration actually used for topical treatment at ocular surface than systemic treatment. MIC90 of each strain was showed in Table 1. The 78 patients received one or more drugs among 11 antimicrobial eye drops or ointment. The rate that can measure the susceptibility of actually used drugs was 100% in SG17 and30.8% in routine method at each institute. In 54(69.2%) patients, the clinical utility of SG17 was better than that of routine method at each institute.

 
Conclusions:
 

These results suggest that SG17 can measure the drug susceptibility of antimicrobial eye drops and it is useful for the treatment of ocular infection.  

 
Keywords: antibiotics/antifungals/antiparasitics • bacterial disease • keratitis 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×